mAMSA resistant human topoisomerase II mutation G465D has reduced ATP hydrolysis activity

Author： Gilroy Kathryn L.   Leontiou Chrysoula   Padget Kay   Lakey Jeremy H.   Austin Caroline A.  

Publisher： Oxford University Press

ISSN： 1362-4962

Source： Nucleic Acids Research, Vol.34, Iss.5, 2006-01, pp. : 1597-1607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP16, using conventional Giemsa staining and chromosome painting techniques

By Mosesso P.  

Mutagenesis, Vol. 13, Iss. 1, 1998-01 ,pp. : 39-43

Oxford University Press

Access to resources Recommend Favorite

ATP Hydrolysis by a CFTR Domain: Pharmacology and Effects of G551D Mutation

By Howell L.D.   Borchardt R.   Cohn J.A.  

Biochemical and Biophysical Research Communications, Vol. 271, Iss. 2, 2000-05 ,pp. : 518-525

Elsevier

Access to resources Recommend Favorite

Response of Purified Mitochondrial DNA Topoisomerase I from Bovine Liver to Camptothecin and m-AMSA

By Lin J.H.   Castora F.J.  

Archives of Biochemistry and Biophysics, Vol. 324, Iss. 2, 1995-12 ,pp. : 293-299

Elsevier

Access to resources Recommend Favorite

Topoisomerase II cleavage activity within the human D11Z1 and DXZ1 alpha-satellite arrays

By Spence Jennifer   Fournier R.   Oshimura Mitsuo   Regnier Vinciane   Farr Christine  

Chromosome Research, Vol. 13, Iss. 6, 2005-08 ,pp. : 637-648

Springer Publishing Company

Access to resources Recommend Favorite

Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase II: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability

By Austin C.A.  

Nucleic Acids Research, Vol. 30, Iss. 24, 2002-12 ,pp. : 5416-5424

Oxford University Press

Access to resources Recommend Favorite